Anna K. Andersson-Hagstrom

Lund, M, Sweden

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 15 publications

The genomic landscape of relapsed infant and childhood KMT2A-rearranged acute leukemia.

The genomic landscape of relapsed infant and childhood KMT2A-rearranged acute leukemia.

Journal: Nature communications

Published: June 07, 2024

Activating mutations remodel the chromatin accessibility landscape to drive distinct regulatory networks in KMT2A-rearranged acute leukemia.

Activating mutations remodel the chromatin accessibility landscape to drive distinct regulatory networks in KMT2A-rearranged acute leukemia.

Journal: HemaSphere

Published: February 22, 2024

Molecular basis for human aquaporin inhibition.

Molecular basis for human aquaporin inhibition.

Journal: Proceedings of the National Academy of Sciences of the United States of America

Published: February 06, 2024

SMS121, a new inhibitor of CD36, impairs fatty acid uptake and viability of acute myeloid leukemia.

SMS121, a new inhibitor of CD36, impairs fatty acid uptake and viability of acute myeloid leukemia.

Journal: Scientific reports

Published: December 28, 2023

Sequential drug treatment targeting cell cycle and cell fate regulatory programs blocks non-genetic cancer evolution in acute lymphoblastic leukemia.

Sequential drug treatment targeting cell cycle and cell fate regulatory programs blocks non-genetic cancer evolution in acute lymphoblastic leukemia.

Journal: Genome biology

Published: May 15, 2023

Combined GLUT1 and OXPHOS inhibition eliminates acute myeloid leukemia cells by restraining their metabolic plasticity.

Combined GLUT1 and OXPHOS inhibition eliminates acute myeloid leukemia cells by restraining their metabolic plasticity.

Journal: Blood advances

Published: February 09, 2023

Duplex Sequencing Uncovers Recurrent Low-frequency Cancer-associated Mutations in Infant and Childhood KMT2A-rearranged Acute Leukemia.

Duplex Sequencing Uncovers Recurrent Low-frequency Cancer-associated Mutations in Infant and Childhood KMT2A-rearranged Acute Leukemia.

Journal: HemaSphere

Published: July 29, 2022

Editorial: Harnessing chemotherapy resistance and development of novel therapeutic strategies for acute leukemia with KMT2A (MLL)-gene rearrangements.

Editorial: Harnessing chemotherapy resistance and development of novel therapeutic strategies for acute leukemia with KMT2A (MLL)-gene rearrangements.

Journal: Frontiers in pharmacology

Published: June 24, 2022

Transcriptomics paving the way for improved diagnostics and precision medicine of acute leukemia.

Transcriptomics paving the way for improved diagnostics and precision medicine of acute leukemia.

Journal: Seminars in cancer biology

Published: March 31, 2021

Aquaglyceroporins and orthodox aquaporins in human adipocytes.

Aquaglyceroporins and orthodox aquaporins in human adipocytes.

Journal: Biochimica et biophysica acta. Biomembranes

Published: March 31, 2021

Targeting GLUT1 in acute myeloid leukemia to overcome cytarabine resistance.

Targeting GLUT1 in acute myeloid leukemia to overcome cytarabine resistance.

Journal: Haematologica

Published: June 20, 2020

CXCR4 Signaling Has a CXCL12-Independent Essential Role in Murine MLL-AF9-Driven Acute Myeloid Leukemia.

CXCR4 Signaling Has a CXCL12-Independent Essential Role in Murine MLL-AF9-Driven Acute Myeloid Leukemia.

Journal: Cell reports

Published: October 25, 2019

Showing 1-12 of 15

Last Updated: 09/26/2026